SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-023014
Filing Date
2023-05-18
Accepted
2023-05-18 16:05:00
Documents
13
Period of Report
2023-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K flgt-20230518.htm   iXBRL 8-K 126085
2 EX-10.1 flgt-ex10_1.htm EX-10.1 141627
  Complete submission text file 0000950170-23-023014.txt   407892

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT flgt-20230518.xsd EX-101.SCH 2482
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT flgt-20230518_pre.xml EX-101.PRE 10560
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT flgt-20230518_lab.xml EX-101.LAB 12798
7 EXTRACTED XBRL INSTANCE DOCUMENT flgt-20230518_htm.xml XML 4527
Mailing Address 4399 SANTA ANITA AVE EL MONTE CA 91731
Business Address 4399 SANTA ANITA AVE EL MONTE CA 91731 626-350-0537
Fulgent Genetics, Inc. (Filer) CIK: 0001674930 (see all company filings)

IRS No.: 812621304 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37894 | Film No.: 23936038
SIC: 8071 Services-Medical Laboratories